XJPX
2201
Market cap1.26bUSD
Oct 08, Last price
2,368.50JPY
1D
0.11%
1Q
-10.82%
Jan 2017
-51.42%
Name
Morinaga & Co Ltd
Chart & performance
P/E
11.19
P/S
0.84
EPS
211.58
Div yield, %
3.91%
Shrs. gr., 5y
-3.50%
Rev. gr., 5y
7.06%
Revenues
236.67b
+3.37%
Net income
17.77b
+0.32%
CFO
23.64b
+119.61%
Dividend
Mar 30, 202735 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Tokyo, Japan, in 1899, Morinaga&Co., Ltd. is a prominent manufacturer, procurer, and distributor of a broad array of consumer products, serving markets both within Japan and internationally. The company's diverse offerings span confectionery items like caramels, biscuits, and chocolates; food staples such as cocoa and cake mixes; frozen desserts, including various ice creams; and health-oriented products like nutritious jelly drinks. Morinaga also extends its reach by providing health foods and beverages through dedicated mail-order services. Its well-known brands encompass a wide selection, featuring popular names such as Morinaga Milk Caramel, HI-CHEW, DARS, Chocoball, ICEBOX, and in Jelly.
Key people
Shinya Mori
President, Chief Operating Officer, Representative Director · since 2025
Eijiro Ohta
Chairman of the Board, Chief Executive Officer, Representative Director · since 2025
Daisuke Fujii
Managing Executive Officer, Director · since 2023
Fumiko Kunichika
Senior Executive Officer, Director of Procurement in Main Production Unit · since 2024
Masaki Matsumoto
Senior Executive Officer, Chief Director of Overseas Business, Director of Overseas Sales in Main Overseas Business · since 2023
Hideki Matsunaga
Senior Executive Officer, Director · since 2022
Isao Matsuzaki
Senior Executive Officer, Director of New Business Development · since 2024
Masaaki Takahashi
Senior Executive Officer · since 2024
Kenji Takanami
Senior Executive Officer, Director · since 2024
Hideharu Watanabe
Senior Executive Officer, Chief Director of Production · since 2021
Minoru Sato
Executive Officer, Director of Health Marketing in Main Marketing Unit · since 2023
Tadashi Ando
Executive Officer, Director of Human Resources · since 2024
Teruji Hyodo
Executive Officer, Director of Sustainable Business Promotion · since 2021
Seiji Kawagishi
Executive Officer, Director of Business Strategy · since 2024
Keisuke Ohashi
Executive Officer, Director of Overseas Strategy in Main Overseas Business Unit · since 2022
Tatsuya Okamura
Executive Officer, Director of Accounting · since 2025
Takanori Sakuragi
Executive Officer, Chief Director of Marketing · since 2024
Minoru Takizawa
Executive Officer, Chief Director of Sales · since 2023
Junji Tsuchiya
Executive Officer, Director of logistics · since 2023
Hiroyuki Watanabe
Executive Officer, Deputy Director of Research Institute · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||